Search Results

GDC-0834 10mg 10mg  | Purity Not Available

Adooq Bioscience

GDC-0834 is a potent and selective inhibitor of Bruton’s tyrosine kinase (BTK), investigated as a potential treatment for rheumatoid arthritis.

More Information Supplier Page

SF1126 50mg 50mg  | Purity Not Available

Adooq Bioscience

SF1126 is a water soluble, small-molecule prodrug containing the pan-PI3K/mTOR inhibitor LY294002/SF1101 conjugated to the RGD-containing tetra-peptide SF1174 with potential antineoplastic and antiangiogenic activities.

More Information Supplier Page

SF1126 5mg 5mg  | Purity Not Available

Adooq Bioscience

SF1126 is a water soluble, small-molecule prodrug containing the pan-PI3K/mTOR inhibitor LY294002/SF1101 conjugated to the RGD-containing tetra-peptide SF1174 with potential antineoplastic and antiangiogenic activities.

More Information Supplier Page

SF1126 25mg 25mg  | Purity Not Available

Adooq Bioscience

SF1126 is a water soluble, small-molecule prodrug containing the pan-PI3K/mTOR inhibitor LY294002/SF1101 conjugated to the RGD-containing tetra-peptide SF1174 with potential antineoplastic and antiangiogenic activities.

More Information Supplier Page

GDC-0834 5mg 5mg  | Purity Not Available

Adooq Bioscience

GDC-0834 is a potent and selective inhibitor of Bruton’s tyrosine kinase (BTK), investigated as a potential treatment for rheumatoid arthritis.

More Information Supplier Page

GDC-0834 50mg 50mg  | Purity Not Available

Adooq Bioscience

GDC-0834 is a potent and selective inhibitor of Bruton’s tyrosine kinase (BTK), investigated as a potential treatment for rheumatoid arthritis.

More Information Supplier Page